Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Shin Poong Pharmaceutical Co. Ltd. clinical trials
The registry lists 27 studies whose lead sponsor is Shin Poong Pharmaceutical Co. Ltd.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 28, 2025.
Keep track of what changes. Save the Shin Poong Pharmaceutical Co. Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Shin Poong Pharmaceutical Co. Ltd..
- Shin Poong Pharmaceutical Co. Ltd.27 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 27 of 27.
- Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential HypertensionEnrolling by invitationNCT07064525Phase 2
- Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of CareRecruitingNCT06660719Phase 3
- Efficacy and Safety of SPC1001 in Patients With Essential HypertensionRecruitingNCT06826872Phase 2
- Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19CompletedNCT04532931Phase 2
- Pivotal Study to Evaluate Efficacy and Safety of SP5M002 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee OsteoarthritisActive, not recruitingNCT06399042Phase 3
- Pivotal Study to Evaluate Efficacy and Safety of SP5M001 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee OsteoarthritisCompletedNCT06307847Phase 3
- A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu TabCompletedNCT06225635Phase 1
- Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential HypertensionCompletedNCT06212648Phase 2
- The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)CompletedNCT05084911Phase 3
- Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPACompletedNCT04479449Phase 2
- Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 PatientsCompletedNCT05633420Phase 2
- A Phase I Study to Evaluate Safety and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356TerminatedNCT05574166Phase 1
- The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 PatientsStatus unknownNCT04701606Phase 2/3
- Spine Surgery for Adhesions in Patients Evaluated for Efficacy and Safety of MedicurtainⓇ (Pivotal Study)CompletedNCT04688281Not applicable
- The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study)CompletedNCT04672421Not applicable
- The Efficacy and Safety of Medicurtain® in Patients With Hysteroscopy (Pivotal Study)CompletedNCT04638855Not applicable
- Anti-adhesive Effect and Safety of MEDICURTAIN Applied to Undergoing Thyroid Surgery (Pivotal Study)CompletedNCT05058027Not applicable
- Efficacy and Safety for Medicurtain® in Prevention of Adhesion After Endoscopic Sinus Surgery (Pivotal Study)CompletedNCT05049434Not applicable
- The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 PatientsCompletedNCT04475107Phase 2
- Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008CompletedNCT04770194Phase 1
- Safety, Tolerability and Pharmacokinetics of SP-8203CompletedNCT01757795Phase 1
- Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPACompletedNCT02787278Phase 2
- Pyramax in Asymptomatic Carriers of P. Falciparum MonoinfectionsStatus unknownNCT03814616Phase 2
- Cohort Event Monitoring Study of Pyramax®CompletedNCT03201770Phase 4
- The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary HypercholesterolemiaCompletedNCT03288038Phase 3
- Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential HypertensionCompletedNCT02944734Phase 2
- Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mgCompletedNCT01926652Phase 1